Astrin Biosciences And Leading New York Cancer Center Announce New Cancer Research Collaboration

NEW YORK, Jan. 24, 2024 /PRNewswire/ -- In a significant advancement for cancer research and treatment, Astrin Biosciences, a leader in AI-empowered 3D holographic technology for cancer cell detection, has announced a comprehensive research collaboration with Memorial Sloan Kettering Cancer Center (MSK). This collaboration will leverage the combined strengths of both organizations, with the goal of transforming biomarker development and its role in cancer research and treatment.

The collaboration sets the stage for an integrated approach, enabling researchers from Astrin and MSK to work together on a wide range of projects across the spectrum of cancer care. The collaboration is fueled by a shared commitment to eradicate the global scourge of cancer.

Astrin's Founder and CEO, Jayant Parthasarathy, PhD, expressed his gratitude and optimism, "We are deeply honored to collaborate with MSK. Their trust in our platform is a testament to our technology's potential. Together, we have a remarkable opportunity to make a significant impact on the lives of those affected by cancer."

"This collaboration holds immense promise for advancing our understanding of cancer, from early detection to addressing the challenges of treatment resistance and disease complexity," said Howard I. Scher, MD, FASCO, Head of MSK's Biomarker Program and a world-renowned expert in cancer diagnostics.

The collaboration promises to accelerate the development of innovative cancer diagnostics and treatments. It underscores the commitment of both Astrin Biosciences and MSK to lead the charge in the global fight against cancer.

For more information about this collaboration, please contact: pr@astrinbio.com

About Astrin Biosciences

Astrin Biosciences is at the forefront of cancer research, revolutionizing the field with its AI-empowered 3D holographic imaging technology for detecting cancer cells. The company is dedicated to harnessing the power of technology to accelerate early detection and advance cancer care (https://astrinbio.com).

View original content to download multimedia:https://www.prnewswire.com/news-releases/astrin-biosciences-and-leading-new-york-cancer-center-announce-new-cancer-research-collaboration-302043912.html

SOURCE Astrin Biosciences

First published on Thu, Jan 25, 2024

Liked what you read? That’s only the tip of the tech iceberg!

Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!

Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.

Dive into TechDogs' treasure trove today and Know Your World of technology like never before!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Tags:

Astrin Biosciences 3D Holographic Imaging Technology AI Biotechnology Research Machine Learning

Join The Discussion

- Promoted By TechDogs -

Biotechnology